These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20535721)

  • 41. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing].
    Liu Q; Zhou S; Qi S; Zeng G; Ma X; Huang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1132-5. PubMed ID: 19952404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Athletes with implantable cardioverter defibrillators: can they return to competitive sports?
    Prutkin JM; Ackerman MJ; Drezner JA
    Heart; 2016 Jan; 102(2):93-4. PubMed ID: 26729607
    [No Abstract]   [Full Text] [Related]  

  • 43. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of sudden cardiac deaths in arrhythmogenic right ventricular cardiomyopathy: how to evaluate risk and when to implant a cardioverter-defibrillator?
    Woźniak O; Włodarska EK
    Cardiol J; 2009; 16(6):588-91. PubMed ID: 19950101
    [No Abstract]   [Full Text] [Related]  

  • 45. Transvenous extraction of an implantable cardioverter-defibrillator lead looped and damaged in subclavian vein.
    Ząbek A; Małecka B; Lelakowski J; Hardzina M; Pfitzner R
    Kardiol Pol; 2013; 71(12):1328. PubMed ID: 24399600
    [No Abstract]   [Full Text] [Related]  

  • 46. Implantable cardioverter defibrillators in children.
    Chun TU; Collins KK; Dubin AM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 49. Inadvertent implantable cardioverter defibrillator lead placement in the left ventricle: long-term follow-up at nine years and management by minimally-invasive surgery.
    Defaye P; Kane A; Jacon P; Obadia J
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):492-3. PubMed ID: 21172950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?
    Nishimura RA; Ommen SR
    JAMA; 2007 Jul; 298(4):452-4. PubMed ID: 17652299
    [No Abstract]   [Full Text] [Related]  

  • 51. Removal of the broken part of implantable cardioverter-defibrillator's electrode causing pulmonary embolism via femoral vein.
    Zencir C; Selvi M; Elbi H; Cetin M; Gungor H; Akgullu C; Badak MI
    Indian Heart J; 2015 Dec; 67 Suppl 3(Suppl 3):S88.e1-4. PubMed ID: 26995444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous extraction of cardiac pacemaker and implantable cardioverter defibrillator leads with evolution mechanical dilator sheath: a single-centre experience.
    Oto A; Aytemir K; Yorgun H; Canpolat U; Kaya EB; Kabakçı G; Tokgözoğlu L; Özkutlu H
    Europace; 2011 Apr; 13(4):543-7. PubMed ID: 21084359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical versus percutaneous removal of a port-A-catheter tip embolized in the peripheral pulmonary artery.
    Abad C; Reina VC; Rodriguez-Suarez PM
    J Vasc Access; 2010; 11(1):73. PubMed ID: 20175057
    [No Abstract]   [Full Text] [Related]  

  • 54. [Non-functional lead as a cause of detection disturbances in implantable cardioverter-defibrillator].
    Kempa M; Budrejko S; Nowakowski M; Królak T; Daniłowicz-Szymanowicz L; Raczak G
    Kardiol Pol; 2012; 70(10):1073-5. PubMed ID: 23080104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unintentional protrusion and trapping of the screw-in helix of an implantable cardioverter defibrillator lead.
    Irie T; Kaneko Y; Nakajima T; Kurabayashi M
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):351. PubMed ID: 21385262
    [No Abstract]   [Full Text] [Related]  

  • 56. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous retrieval of an embolized pacemaker lead from the pulmonary artery.
    Ruparelia N; Newton J; Ormerod OJ; Bhindi R
    Int J Cardiol; 2011 Jun; 149(3):e106-7. PubMed ID: 19545920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].
    Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K
    Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.